debio-1347 and Glioma

debio-1347 has been researched along with Glioma* in 1 studies

Other Studies

1 other study(ies) available for debio-1347 and Glioma

ArticleYear
Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas.
    JCO precision oncology, 2021, Volume: 5

    Topics: Adolescent; Benzimidazoles; Brain Neoplasms; Child; Child, Preschool; Glioma; Humans; Infant; Pyrazoles; Receptors, Fibroblast Growth Factor

2021